DK141786D0 - Fremgangsmaade til fremstilling af et mellemprodukt til brug ved fremstilling af 1-beta-methylcarbapenemantibiotika - Google Patents

Fremgangsmaade til fremstilling af et mellemprodukt til brug ved fremstilling af 1-beta-methylcarbapenemantibiotika

Info

Publication number
DK141786D0
DK141786D0 DK141786A DK141786A DK141786D0 DK 141786 D0 DK141786 D0 DK 141786D0 DK 141786 A DK141786 A DK 141786A DK 141786 A DK141786 A DK 141786A DK 141786 D0 DK141786 D0 DK 141786D0
Authority
DK
Denmark
Prior art keywords
compound
alkyl
chem
preparation
proviso
Prior art date
Application number
DK141786A
Other languages
English (en)
Other versions
DK141786A (da
Inventor
Thomas N Salzmann
Lelia M Fuentes
Ichiro Shinkai
Original Assignee
Merck & Co Inc
Priority date (The priority date is an assumption and is not a legal conclusion. Google has not performed a legal analysis and makes no representation as to the accuracy of the date listed.)
Filing date
Publication date
Application filed by Merck & Co Inc filed Critical Merck & Co Inc
Publication of DK141786D0 publication Critical patent/DK141786D0/da
Publication of DK141786A publication Critical patent/DK141786A/da

Links

Classifications

    • C—CHEMISTRY; METALLURGY
    • C07—ORGANIC CHEMISTRY
    • C07D—HETEROCYCLIC COMPOUNDS
    • C07D413/00—Heterocyclic compounds containing two or more hetero rings, at least one ring having nitrogen and oxygen atoms as the only ring hetero atoms
    • C07D413/02—Heterocyclic compounds containing two or more hetero rings, at least one ring having nitrogen and oxygen atoms as the only ring hetero atoms containing two hetero rings
    • C07D413/06—Heterocyclic compounds containing two or more hetero rings, at least one ring having nitrogen and oxygen atoms as the only ring hetero atoms containing two hetero rings linked by a carbon chain containing only aliphatic carbon atoms
    • A—HUMAN NECESSITIES
    • A61—MEDICAL OR VETERINARY SCIENCE; HYGIENE
    • A61P—SPECIFIC THERAPEUTIC ACTIVITY OF CHEMICAL COMPOUNDS OR MEDICINAL PREPARATIONS
    • A61P31/00—Antiinfectives, i.e. antibiotics, antiseptics, chemotherapeutics
    • A61P31/04—Antibacterial agents
    • C—CHEMISTRY; METALLURGY
    • C07—ORGANIC CHEMISTRY
    • C07D—HETEROCYCLIC COMPOUNDS
    • C07D205/00—Heterocyclic compounds containing four-membered rings with one nitrogen atom as the only ring hetero atom
    • C07D205/02—Heterocyclic compounds containing four-membered rings with one nitrogen atom as the only ring hetero atom not condensed with other rings
    • C07D205/06—Heterocyclic compounds containing four-membered rings with one nitrogen atom as the only ring hetero atom not condensed with other rings having one double bond between ring members or between a ring member and a non-ring member
    • C07D205/08—Heterocyclic compounds containing four-membered rings with one nitrogen atom as the only ring hetero atom not condensed with other rings having one double bond between ring members or between a ring member and a non-ring member with one oxygen atom directly attached in position 2, e.g. beta-lactams
    • C—CHEMISTRY; METALLURGY
    • C07—ORGANIC CHEMISTRY
    • C07D—HETEROCYCLIC COMPOUNDS
    • C07D263/00—Heterocyclic compounds containing 1,3-oxazole or hydrogenated 1,3-oxazole rings
    • C07D263/02—Heterocyclic compounds containing 1,3-oxazole or hydrogenated 1,3-oxazole rings not condensed with other rings
    • C07D263/08—Heterocyclic compounds containing 1,3-oxazole or hydrogenated 1,3-oxazole rings not condensed with other rings having one double bond between ring members or between a ring member and a non-ring member
    • C07D263/16—Heterocyclic compounds containing 1,3-oxazole or hydrogenated 1,3-oxazole rings not condensed with other rings having one double bond between ring members or between a ring member and a non-ring member with hetero atoms or with carbon atoms having three bonds to hetero atoms with at the most one bond to halogen, e.g. ester or nitrile radicals, directly attached to ring carbon atoms
    • C07D263/18—Oxygen atoms
    • C07D263/20—Oxygen atoms attached in position 2
    • C07D263/22—Oxygen atoms attached in position 2 with only hydrogen atoms or radicals containing only hydrogen and carbon atoms, directly attached to other ring carbon atoms
    • C—CHEMISTRY; METALLURGY
    • C07—ORGANIC CHEMISTRY
    • C07D—HETEROCYCLIC COMPOUNDS
    • C07D263/00—Heterocyclic compounds containing 1,3-oxazole or hydrogenated 1,3-oxazole rings
    • C07D263/02—Heterocyclic compounds containing 1,3-oxazole or hydrogenated 1,3-oxazole rings not condensed with other rings
    • C07D263/08—Heterocyclic compounds containing 1,3-oxazole or hydrogenated 1,3-oxazole rings not condensed with other rings having one double bond between ring members or between a ring member and a non-ring member
    • C07D263/16—Heterocyclic compounds containing 1,3-oxazole or hydrogenated 1,3-oxazole rings not condensed with other rings having one double bond between ring members or between a ring member and a non-ring member with hetero atoms or with carbon atoms having three bonds to hetero atoms with at the most one bond to halogen, e.g. ester or nitrile radicals, directly attached to ring carbon atoms
    • C07D263/18—Oxygen atoms
    • C07D263/20—Oxygen atoms attached in position 2
    • C07D263/26—Oxygen atoms attached in position 2 with hetero atoms or acyl radicals directly attached to the ring nitrogen atom
    • C—CHEMISTRY; METALLURGY
    • C07—ORGANIC CHEMISTRY
    • C07D—HETEROCYCLIC COMPOUNDS
    • C07D277/00—Heterocyclic compounds containing 1,3-thiazole or hydrogenated 1,3-thiazole rings
    • C07D277/02—Heterocyclic compounds containing 1,3-thiazole or hydrogenated 1,3-thiazole rings not condensed with other rings
    • C07D277/08—Heterocyclic compounds containing 1,3-thiazole or hydrogenated 1,3-thiazole rings not condensed with other rings having one double bond between ring members or between a ring member and a non-ring member
    • C07D277/12—Heterocyclic compounds containing 1,3-thiazole or hydrogenated 1,3-thiazole rings not condensed with other rings having one double bond between ring members or between a ring member and a non-ring member with hetero atoms or with carbon atoms having three bonds to hetero atoms with at the most one bond to halogen, e.g. ester or nitrile radicals, directly attached to ring carbon atoms
    • C—CHEMISTRY; METALLURGY
    • C07—ORGANIC CHEMISTRY
    • C07D—HETEROCYCLIC COMPOUNDS
    • C07D417/00—Heterocyclic compounds containing two or more hetero rings, at least one ring having nitrogen and sulfur atoms as the only ring hetero atoms, not provided for by group C07D415/00
    • C07D417/02—Heterocyclic compounds containing two or more hetero rings, at least one ring having nitrogen and sulfur atoms as the only ring hetero atoms, not provided for by group C07D415/00 containing two hetero rings
    • C07D417/06—Heterocyclic compounds containing two or more hetero rings, at least one ring having nitrogen and sulfur atoms as the only ring hetero atoms, not provided for by group C07D415/00 containing two hetero rings linked by a carbon chain containing only aliphatic carbon atoms
    • Y—GENERAL TAGGING OF NEW TECHNOLOGICAL DEVELOPMENTS; GENERAL TAGGING OF CROSS-SECTIONAL TECHNOLOGIES SPANNING OVER SEVERAL SECTIONS OF THE IPC; TECHNICAL SUBJECTS COVERED BY FORMER USPC CROSS-REFERENCE ART COLLECTIONS [XRACs] AND DIGESTS
    • Y02—TECHNOLOGIES OR APPLICATIONS FOR MITIGATION OR ADAPTATION AGAINST CLIMATE CHANGE
    • Y02P—CLIMATE CHANGE MITIGATION TECHNOLOGIES IN THE PRODUCTION OR PROCESSING OF GOODS
    • Y02P20/00—Technologies relating to chemical industry
    • Y02P20/50—Improvements relating to the production of bulk chemicals
    • Y02P20/55—Design of synthesis routes, e.g. reducing the use of auxiliary or protecting groups

Landscapes

  • Chemical & Material Sciences (AREA)
  • Organic Chemistry (AREA)
  • Health & Medical Sciences (AREA)
  • Life Sciences & Earth Sciences (AREA)
  • General Health & Medical Sciences (AREA)
  • Chemical Kinetics & Catalysis (AREA)
  • General Chemical & Material Sciences (AREA)
  • Medicinal Chemistry (AREA)
  • Nuclear Medicine, Radiotherapy & Molecular Imaging (AREA)
  • Pharmacology & Pharmacy (AREA)
  • Communicable Diseases (AREA)
  • Animal Behavior & Ethology (AREA)
  • Oncology (AREA)
  • Public Health (AREA)
  • Veterinary Medicine (AREA)
  • Organic Low-Molecular-Weight Compounds And Preparation Thereof (AREA)
  • Nitrogen Condensed Heterocyclic Rings (AREA)
  • Pharmaceuticals Containing Other Organic And Inorganic Compounds (AREA)
  • Plural Heterocyclic Compounds (AREA)
  • Thiazole And Isothizaole Compounds (AREA)
  • Heterocyclic Carbon Compounds Containing A Hetero Ring Having Nitrogen And Oxygen As The Only Ring Hetero Atoms (AREA)
  • Medicines Containing Material From Animals Or Micro-Organisms (AREA)
  • Low-Molecular Organic Synthesis Reactions Using Catalysts (AREA)
DK141786A 1985-03-29 1986-03-26 Fremgangsmaade til fremstilling af et mellemprodukt til brug ved fremstilling af 1-beta-methylcarbapenemantibiotika DK141786A (da)

Applications Claiming Priority (3)

Application Number Priority Date Filing Date Title
US71774685A 1985-03-29 1985-03-29
US71734285A 1985-03-29 1985-03-29
US71774285A 1985-03-29 1985-03-29

Publications (2)

Publication Number Publication Date
DK141786D0 true DK141786D0 (da) 1986-03-26
DK141786A DK141786A (da) 1986-09-30

Family

ID=27418970

Family Applications (1)

Application Number Title Priority Date Filing Date
DK141786A DK141786A (da) 1985-03-29 1986-03-26 Fremgangsmaade til fremstilling af et mellemprodukt til brug ved fremstilling af 1-beta-methylcarbapenemantibiotika

Country Status (8)

Country Link
EP (1) EP0197432B1 (da)
JP (2) JPH05320171A (da)
AT (1) ATE107278T1 (da)
CA (3) CA1276156C (da)
DE (1) DE3689911D1 (da)
DK (1) DK141786A (da)
ES (1) ES8800215A1 (da)
IE (1) IE860840L (da)

Families Citing this family (10)

* Cited by examiner, † Cited by third party
Publication number Priority date Publication date Assignee Title
EP0229384B1 (en) * 1985-12-28 1994-08-10 Sumitomo Pharmaceuticals Company, Limited Beta-lactam compounds and their production
US5231179A (en) * 1986-01-27 1993-07-27 Sumitomo Pharmaceuticals Company, Limited Heterocyclic compounds and their production
JP2789190B2 (ja) * 1986-01-27 1998-08-20 住友製薬株式会社 新規なβ−ラクタム誘導体およびその製造法
GB8607921D0 (en) * 1986-04-01 1986-05-08 Fujisawa Pharmaceutical Co 3,4-disubstituted-2-azetidinone derivatives
DE3767004D1 (de) * 1986-04-07 1991-02-07 Merck & Co Inc Verfahren zur herstellung von 1-betamethylcarbapenem-antibiotikum-zwischenprodukten.
US5550229A (en) * 1993-06-23 1996-08-27 Tanabe Seiyaku Co., Ltd. Alkylation process for preparing azetidinone compound and starting compound therefor
DE69405922T2 (de) * 1993-06-30 1998-01-29 Nippon Soda Co Verfahren zur Herstellung von 4-substituierten Azetidinon-Derivaten
JP3450193B2 (ja) * 1998-07-24 2003-09-22 高砂香料工業株式会社 ４−置換アゼチジノン誘導体の製造方法
CN113817299B (zh) * 2021-08-18 2022-12-13 安徽建筑大学 一种具有离子和化学双重交联结构的pla基共混复合材料及其制备方法
CN113970500B (zh) * 2021-10-27 2023-08-29 北京新风航天装备有限公司 一种油污固废含油率快速测定方法

Family Cites Families (6)

* Cited by examiner, † Cited by third party
Publication number Priority date Publication date Assignee Title
US2399118A (en) 1942-02-13 1946-04-23 Mallinckrodt Chemical Works 2-oxazolidone compounds and method for preparing the same
US3950357A (en) 1974-11-25 1976-04-13 Merck & Co., Inc. Antibiotics
US4194047A (en) 1975-11-21 1980-03-18 Merck & Co., Inc. Substituted N-methylene derivatives of thienamycin
US4383946A (en) 1980-03-27 1983-05-17 Merck & Co., Inc. Process for the preparation of 1-carbapenems and intermediates via silyl-substituted dithioacetals
ES8404184A1 (es) * 1981-08-03 1984-04-16 Merck & Co Inc Un procedimiento para la prepracion de nuevos derivados de acidos 2-carbamimidoil-1-,carbadestiapen-2-en-3-carboxilados.
JPS6019763A (ja) 1983-07-13 1985-01-31 Sankyo Co Ltd アゼチジノンチオエステル類の製造法

Also Published As

Publication number Publication date
DK141786A (da) 1986-09-30
CA1276156C (en) 1990-11-13
ES553461A0 (es) 1987-10-16
CA1319697C (en) 1993-06-29
ATE107278T1 (de) 1994-07-15
JPH05320171A (ja) 1993-12-03
ES8800215A1 (es) 1987-10-16
DE3689911D1 (de) 1994-07-21
IE860840L (en) 1986-09-29
EP0197432B1 (en) 1994-06-15
EP0197432A2 (en) 1986-10-15
JPH05320159A (ja) 1993-12-03
CA1279649C (en) 1991-01-29
EP0197432A3 (en) 1987-01-21

Similar Documents

Publication Publication Date Title
ES2005745A6 (es) Un procedimiento para preparar arilpiperindionas.
KR860008967A (ko) 입체 장해된 하이드록시페닐카복실 산 에스테르의 제조방법
ES2000604A6 (es) Un procedimiento para preparar aril-piperidin esteres
DK141786A (da) Fremgangsmaade til fremstilling af et mellemprodukt til brug ved fremstilling af 1-beta-methylcarbapenemantibiotika
ES2057757T3 (es) Procedimiento para preparar derivados de 1,5-benzotiazepina.
KR850005838A (ko) 1,3,2-디옥사보리난의 제조방법
KR840000530A (ko) 신규 벤조트리아졸의 제조방법
DE69714749D1 (de) Verfahren zur herstellung von 3-amino-2-hydroxy-1-propylethern
EP0206765A3 (en) Process for preparation of rooperol, hypoxoside and derivatives thereof
ATE13058T1 (de) Verfahren zur herstellung eines furanderivates.
ATE18208T1 (de) N-(4-hydroxyphenyl)essigsaeureamid-estern aus 5benzoyl-1-methylpyrrol-2-essigsaeure.
DE69024114D1 (de) Verfahren zur Herstellung von Penemen
ATE25680T1 (de) Verfahren zur herstellung von 4-amino-5-dialkoxy- methylpyrimidinderivaten.
ATE55372T1 (de) Verfahren zur herstellung von 4-chlorbutanalen.
DE3772703D1 (de) Verfahren zur herstellung von penemen.
PT84870A (pt) Processo para a preparacao de derivados da cefalosporina
ES488385A0 (es) Procedimiento de preparacion de derivados de la xantona
ATE24507T1 (de) Verfahren zur herstellung von lysergsaeure-estern.
DE3864163D1 (de) Beta-lactam-verbindungen und verfahren zu deren herstellung.
ATE90101T1 (de) Verfahren zur herstellung von makrolid-derivaten.
SU1039167A1 (ru) Способ получения производных 4-тиазолинкарбоновой кислоты
ATE77373T1 (de) Verfahren zur herstellung von chinolinsaeurederivaten.

Legal Events

Date Code Title Description
AHS Application shelved for other reasons than non-payment